Sat, Jul 12, 2014, 4:10 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Apricus Biosciences, Inc. Message Board

  • mecosmo2 mecosmo2 Jan 9, 2014 5:53 PM Flag

    Corporate Uodate from Apricus RTD room temperature see web site

    2014 Strategic Focus
    Strategic Objective…
    Anticipated Value Drivers…
    Launch Vitaros® RTD in 2015 to extend its long-term market potential and to fully penetrate ROW markets
    2.Complete the development of the Vitaros® Room Temperature Device (RTD) in 2014
    Generate meaningful long-term revenue to support corporate strategy
    1.Launch Vitaros® in Europe and Canada in 2014
    3.Leverage existing platform to build pipeline in men’s and women’s health
    Develop existing and/or acquired assets focused on enhancing men’s and women’s health and well-being
    Create near-term shareholder value through partnering our existing commercial and development-stage assets (e.g. Vitaros® ROW, Femprox EU)
    4.Continue to seek additional strategic partnerships for Vitaros® and Femprox®
    Position company to create shareholder value through the pursuit of strategic partnerships
    5.Establish Apricus as a leader in the development of novel men’s and women’s Rx therapeutics

    Sentiment: Strong Buy

 
APRI
2.09+0.01(+0.48%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.